Riskpilot← Back to searchSign inGet full accessNanosep Analytical AB
ABIn liquidationOrg 5568949324Technical testing and analysis · NACE 7120Est. 20120 employees
Revenue 2021
SEK 0
EBITDA margin
—
Equity ratio
100.0%
Financial strength
Net profit 2021
SEK 0
0 employees
| Revenue | SEK 0 | — |
| EBITDA | — | — |
| Net profit | SEK 0 | — |
| Total assets | SEK 10K | +900% |
| Equity | SEK 10K | +900% |
| Employees | 0 | — |
Legal name
Nanosep Analytical AB
Org number
5568949324
Legal form
Aktiebolag
NACE code
7120 · Technical testing and analysis
Founded
1 juni 2012
Share capital
SEK 0
Employees
0
VAT registered
No
Audit selected
No
Last report
2021-04-30
Financial year
January – December
Company purpose
Utveckling och försäljning av analysprocesser och kemiska analysprodukter baserat på nanoteknik. Utveckling och försäljning av analytiska tekniker för kunder inom farmaceutisk och bioteknisk industri. Licensförsäljning. Bolaget skall även förvalta lös och fast egendom samt därmed förenlig verksamhet.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −12 | −5 | −2 | — | — |
| Depreciation & amort. | −7 | −1 | −0 | −0 | −0 |
| EBIT | −19 | −6 | −2 | 0 | 0 |
| Net financials | — | — | — | — | — |
| Profit before tax | −19 | −6 | −2 | 0 | 0 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −19 | −6 | −2 | 0 | 0 |
| Item | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|
| Total assets | 10 | 3 | 1 | 1 | 10 |
| Equity | 8 | 3 | 1 | 1 | 10 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 1 | 0 | 0 | 0 | 0 |
| Total debt | 1 | — | — | — | — |
EBITDA margin
0.0%
This company
15.8%
Market median
-100% vs market
20172021
Equity ratio
100.0%
This company
38.2%
Market median
+162% vs market
20172021
Return on equity
0.0%
This company
18.4%
Market median
-100% vs market
20172021
Net profit margin
0.0%
This company
8.1%
Market median
-100% vs market
20172021
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20172021
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20172021
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-05-01 – 2021-04-30
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-05-01 – 2020-04-30
- Annual report 2019Filed via Bolagsverket / SCB · Period 2018-05-01 – 2019-04-30
- Annual report 2018Filed via Bolagsverket / SCB · Period 2017-05-01 – 2018-04-30
- Annual report 2017Filed via Bolagsverket / SCB · Period 2016-05-01 – 2017-04-30
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
LG External Signatory | External Signatory | 2021 |
KO Liquidator | Liquidator | 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Deputy Board Member | 2021 | |
| Deputy Board Member | 2021 | |
| Board of Directors | 2021 | |
| Former (4) | ||
| Board of Directors | 2021 – 2021 | |
| Board of Directors | 2021 – 2021 | |
| Chairman | 2021 – 2021 | |
| Board of Directors | 2021 – 2021 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Nanosep Analytical AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Leif Gustav Andersson | External Signatory | 0 companies |
| Knut Olof Mikael Rosén | Liquidator | 0 companies |
| Per Jonas Bergquist | Board of Directors | 0 companies |
| Inger Margareta Dahle | Deputy Board Member | 0 companies |
| Annika Jeanette Andersson | Board of Directors | 0 companies |
| Bengt Junior Niklas Nygårds | Deputy Board Member | 0 companies |
| Ulrika Margareta Ahlholm | Board of Directors | 0 companies |
| Per Åke Oldentoft | Chairman | 0 companies |
| Bengt Patrik Söderlund | Board of Directors | 0 companies |